| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |